A detailed history of State Of Alaska, Department Of Revenue transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 17,190 shares of HRMY stock, worth $575,521. This represents 0.01% of its overall portfolio holdings.

Number of Shares
17,190
Previous 18,673 7.94%
Holding current value
$575,521
Previous $563,000 22.02%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$30.0 - $39.95 $44,490 - $59,245
-1,483 Reduced 7.94%
17,190 $687,000
Q2 2024

Aug 05, 2024

SELL
$28.81 - $33.01 $37,712 - $43,210
-1,309 Reduced 6.55%
18,673 $563,000
Q1 2024

Apr 19, 2024

SELL
$29.93 - $35.06 $5,896 - $6,906
-197 Reduced 0.98%
19,982 $670,000
Q4 2023

Jan 19, 2024

SELL
$19.2 - $33.78 $14,208 - $24,997
-740 Reduced 3.54%
20,179 $651,000
Q3 2023

Oct 16, 2023

BUY
$31.89 - $39.03 $37,917 - $46,406
1,189 Added 6.03%
20,919 $685,000
Q2 2023

Jul 24, 2023

SELL
$30.5 - $37.4 $17,690 - $21,692
-580 Reduced 2.86%
19,730 $694,000
Q1 2023

Apr 17, 2023

SELL
$30.8 - $53.92 $10,071 - $17,631
-327 Reduced 1.58%
20,310 $663,000
Q4 2022

Jan 11, 2023

BUY
$45.4 - $60.91 $7,127 - $9,562
157 Added 0.77%
20,637 $1.14 Million
Q3 2022

Oct 20, 2022

BUY
$42.06 - $55.45 $128,703 - $169,677
3,060 Added 17.57%
20,480 $907,000
Q2 2022

Jul 08, 2022

BUY
$33.54 - $52.15 $52,322 - $81,354
1,560 Added 9.84%
17,420 $849,000
Q1 2022

Apr 14, 2022

SELL
$33.14 - $51.13 $9,610 - $14,827
-290 Reduced 1.8%
15,860 $771,000
Q4 2021

Jan 12, 2022

BUY
$34.09 - $43.91 $550,553 - $709,146
16,150 New
16,150 $688,000

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $1.98B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track State Of Alaska, Department Of Revenue Portfolio

Follow State Of Alaska, Department Of Revenue and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Alaska, Department Of Revenue, based on Form 13F filings with the SEC.

News

Stay updated on State Of Alaska, Department Of Revenue with notifications on news.